| First Author | Kato M | Year | 1999 |
| Journal | Mol Reprod Dev | Volume | 54 |
| Issue | 1 | Pages | 43-8 |
| PubMed ID | 10423296 | Mgi Jnum | J:56534 |
| Mgi Id | MGI:1341511 | Doi | 10.1002/(SICI)1098-2795(199909)54:1<43::AID-MRD6>3.0.CO;2-N |
| Citation | Kato M, et al. (1999) Efficient selection of transgenic mouse embryos using EGFP as a marker gene. Mol Reprod Dev 54(1):43-8 |
| abstractText | We have established a reliable method that uses the EGFP (Enhanced Green Fluorescent Protein) gene as a marker for selecting transgenic embryos from preimplantation embryos. Embryos that were subjected to the pronuclear microinjection of the CMV/beta-actin/EGFP fusion gene were cultured in vitro until they developed into the morulae- or blastocyst-stage. The expression of EGFP was easily observed by a fluorescent microscopy. There appeared to be no damage to the in vivo developmental ability of the embryos in response to the EGFP excitation light, which utilized an IB filter for a period of 30 min. Modified PCR analysis using Dpn I and Bal 31 digestion of the embryonic DNA showed that all of the embryos expressing EGFP in all their cells were transgenic, while more than half with mosaic expression of EGFP were not transgenic. Approximately 77% of pups born from the embryos that uniformly expressed the EGFP gene were transgenic, while 21.4% of pups from the embryos with mosaic expression were transgenics. The results showed that the use of EGFP as a marker is very useful and reliable for selecting transgenic embryos, and that it is important to transfer the embryos expressing EGFP in all their cells to obtain truly transgenic animals. Copyright 1999 Wiley-Liss, Inc. |
